Trading Window Closed from Oct 1 for Vanta Bioscience Half-Year Results

Compliance View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+5.0%Reaction day

₹20.53

prior close

₹21.55

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+1.0%+3.9% vs market

Healthcare Services peers, median of 66sector · industry level-0.7%+5.7% vs sector

On the reaction day the stock moved 3.9 pts more than Nifty Microcap 250 and 5.7 pts more than its Healthcare Services peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+5.0+1.0+3.9-0.7+5.7

Next day

+10.2+0.8+9.4-2.1+12.2

+4.7-0.5+5.2-3.2+7.9

-0.5-0.5-0.0-3.6+3.0

-0.5+0.8-1.3-3.1+2.6

—+0.5—-3.9—

—-2.0—-5.5—

15d

—-6.4—-10.3—

—————

UpDownMarket · Nifty Microcap 250Sector · Healthcare Services peers, median of 66Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Vanta Bioscience has closed its trading window from October 1, 2026, until 48 hours after it declares unaudited half-year financial results for the period ended September 30, 2026. The closure applies to all designated persons and their immediate relatives, as required by SEBI insider trading rules. The board meeting date to approve these results will be announced later.

Likely market impact

Standard insider trading window closure ahead of results. Insiders cannot trade until 48 hours after H1 FY26 results are declared.